Published Date: Wed, Jul 22, 2026 NEW
Highmark Healthy Kids (CHIP) encourages PCPs to provide annual chlamydia screenings for sexually active cisgender women and persons assigned female at birth (hereinafter “females”) ages 16+ and to educate members on routine testing. This screening is part of the NCQA HEDIS® Chlamydia Screening (CHL) measure.
According to the 2023 STI Surveillance Report by the Centers for Disease Control and Prevention, chlamydia is the most commonly reported sexually transmitted infection (STI) in the U.S.
Screening is critical because many females are asymptomatic; early detection and treatment help prevent serious complications, such as pelvic inflammatory disease, infertility, and ectopic pregnancy.
We understand that discussing this topic can be uncomfortable, but it plays a critical role in promoting adolescent health and safety.
Use well-child visits to perform annual chlamydia screening females ages 16-19 who identified as being sexually active.
*HEDIS® — an acronym for Healthcare Effectiveness Data and Information Set — is a registered trademark of NCQA.
Quick Info
Never miss out on what matters. Subscribe to our emails and stay informed.